Global Markets React to Meta’s EU AI Stance, Strong US Consumer Sentiment, and Easing Inflation
Key Takeaways Meta Platforms (META) has notably refused to sign the EU’s voluntary Code of Practice for general-purpose AI, becoming […]
Breaking News
Financial Markets Open Higher Amid Stablecoin Concerns and Tariff Discussions
U.S. Equities Open Strong: Major U.S. stock indices began the trading day with gains, indicating a positive market sentiment. The
G20 Leaders Confront Global Economic Headwinds, Reaffirm Commitment to Stability and Cooperation
G20 finance leaders have underscored the critical importance of central bank independence for achieving price stability, a core objective amidst
Moderna Scraps Japan mRNA Plant Amid Weakening Global Demand
Moderna (MRNA) has announced the cancellation of its plans to construct a messenger RNA (mRNA) manufacturing facility in Japan, attributing
U.S. Housing Starts Surge, Treasury Yields Dip as Fed’s Waller Weighs In on Economy and Tariffs
U.S. Housing Market Shows Unexpected Strength in June The U.S. housing market demonstrated surprising resilience in June, with housing starts
Tech Regulatory Tensions Rise as Meta Rejects EU AI Code; Porsche Cuts Costs Amid China Slump
Meta (META) has signaled a significant divergence from European regulatory efforts, with its Chief Global Affairs Officer, Joel Kaplan, declaring
Strong Earnings from American Express and Charles Schwab, Bristol Myers’ Drug Trial Misses Endpoint
Key Takeaways: American Express (AXP) reported robust Q2 2025 results, significantly surpassing analyst expectations for both revenue and EPS, driven
Global Economy Navigates Trade Tensions and Earnings Season Surprises
SLB (SLB) delivered a robust performance in the second quarter of 2025, with revenue reaching $8.55 billion, exceeding estimates of
Corporate Earnings Boost Markets Amidst Key Trade Talks and Geopolitical Tensions
3M (MMM) delivered a robust performance in the second quarter of 2025, reporting adjusted sales of $6.2 billion, surpassing the
Geopolitical Tensions Escalate Amidst Key Corporate Developments and Economic Signals
Key Takeaways: Moderna (MRNA) has reportedly canceled plans for an MRNA plant in Japan due to low demand, according to